Panbela Therapeutics, Inc. Deferred Revenue
Panbela Therapeutics, Inc. had Deferred Revenue of $5.53 thousand as of 2015-06-30, per its 10-Q filed 2015-08-13.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DeferredRevenueCurrent · last filed 2015-08-13
- 2015-06-30: Deferred Revenue, Current $5.53K.
- 2015-03-31: Deferred Revenue, Current $14.32K.
- 2014-12-31: Deferred Revenue, Current $18.93K.
- 2014-09-30: Deferred Revenue, Current $28.45K.
| Period end | Deferred Revenue, Current |
|---|---|
| 2015-06-30 | $5.53K 10-Q · filed 2015-08-13 |
| 2015-03-31 | $14.32K 10-Q · filed 2015-05-15 |
| 2014-12-31 | $18.93K 10-Q · filed 2015-08-13 |
| 2014-09-30 | $28.45K 10-Q · filed 2014-11-14 |
| 2014-06-30 | $11.89K 10-Q · filed 2014-08-14 |
| 2014-03-31 | $22.86K 10-Q · filed 2014-05-15 |
| 2013-12-31 | $33.04K 10-K · filed 2015-03-30 |
| 2013-09-30 | $46.65K 10-Q · filed 2013-11-14 |
| 2013-06-30 | $35.26K 10-Q · filed 2013-08-14 |
| 2013-03-31 | $18.43K 10-Q · filed 2013-05-15 |
| 2012-12-31 | $27.04K 10-K · filed 2014-03-28 |
| 2011-12-31 | $24.48K 10-K · filed 2013-03-26 |